International Year of Chemistry, 2011

UNESCO - United Nations Educational, Scientific and Cultural Organization

Partners for the
International Year of Chemistry 2011

See all Activities

Opportunities for commercialising drug discovery in the academic sector

Activity by Jacqui Colgate   |   added on Nov 18, 2010   |   United Kingdom Official_iyc_logo

Sponsor(s): Medical Research Council Technology

Converting early stage research into commercially valuable drug discovery assets

Opportunities for commercialising drug discovery in the academic sector

SCI HQ, London, UK
17 February 2011, 09.30 - 18.30
Organised by SCI's Science and Enterprise Group


The aim of this event is to highlight the apparent development gap that exists between academia and the pharmaceutical industry and to discuss mechanisms by which this gap can be bridged. Topics include the development of partnerships between academia/industry, sources of funding and the current investment climate. Case studies will be used as examples throughout the day. Representatives from both the academic and pharmaceutical sectors will be in attendance to share their insights, with networking opportunities available.

Who should attend

This one day conference is for anyone involved with the development of early stage drug discovery opportunities, including technology transfer representatives and researchers. In addition, this event will be of interest to individuals from the pharmaceutical industry associated with the identification and licensing of projects from academia and the promotion of external alliances.


Please click here to view the full programme.




Registration and refreshments






Facilitating partnerships between pharma and academia
Dr Alan Lamont, AstraZeneca



The Imperial Drug Discovery Centre; enabling translation of academic projects towards commercial reality
Dr Cathy Tralau-Stewart, Imperial College Drug Discovery Centre


Refreshment break


Commercialising IP the Oxford Way
Ms Linda Naylor, Oxford University


Thiakis: from conception to exit
Prof Steve Bloom, Imperial College and Thiakis founder


Lunch (kindly sponsored by MRCT)


The Role of Public � Private partnerships in Pharmaceutical R&D
Dr Dave Tapolczay, MRCT


Wellcome Trust approaches to support innovative drug discovery
Dr Richard Davis, Wellcome Trust


Refreshment break


Mordern Biosciences: development of late-stage discovery projects from academia
Dr Sam Williams, Modern Biosciences�



Investment in drug discovery... does it make sense? and who are the investors?
Dr Andy Richards, Business Angel


Wine reception and networking

Organising Committee

Dr Kirsty Hewitson, Union Life Sciences Ltd
Dr David Lawrence, Syngenta Ltd


SCI HQ, London, UK
Please click here for a location map.

Delegate Fees

Please note fees include the 5% discount for making an online booking

Earlybird fees - before 17 January
GB�90.00 . . . . . . . . . SCI Member
GB�30.00 . . . . . . . ... SCI Student
GB�60.00 . . . . . . . ... Subsidised Member
GB�120.00 . . . . . . . . Non Member

Standard fees - after 17 January
GB�105.00 . . . . . . . . SCI Member
GB�35.00 . . . . . . . . ..SCI Student
GB�70.00 . . . . . . . . . Subsidised Member
GB�140.00 . . . . . . . . Non Member

With thanks to our Sponsor:


MRC Technology works with scientists from Medical Research Council-funded Units and collaborating organisations to discover and protect healthcare innovations. They combine technology transfer, small molecule drug discovery and therapeutic antibody functions in order to convert knowledge into commercial success.

For more information, please contact:

Conference Team
T: +44 (0)20 7598 1561
F: +44 (0)20 7235 7743

Topic: celebrating chemistry, conferences, chemistry education, networking Audience: students, professional chemists, educators, industrial chemists, professors, general public, universities, post graduate students, decision makers, research scientists, women chemists
Want to submit your own activity or comment?

In order to do so you need to be part of the IYC network. Please or sign up now.

Join the IYC Network

Share |